Dr. Krishnadasan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3838 N Campbell Ave
Tucson, AZ 85719Phone+1 520-694-2873Fax+1 520-694-0848
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
- Norwalk Hospital/Yale UniversityResidency, Internal Medicine, 2000 - 2003
- St. George's University School of MedicineClass of 2000
Certifications & Licensure
- AZ State Medical License 2008 - 2025
- RI State Medical License 2006 - 2010
Clinical Trials
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Start of enrollment: 2009 Jan 29
- Cytarabine and Daunorubicin Hydrochloride or Idarubicin and Cytarabine With or Without Vorinostat in Treating Younger Patients With Previously Untreated Acute Myeloid Leukemia Start of enrollment: 2013 Feb 12
Publications & Presentations
PubMed
- 34 citationsA phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.Amer M Zeidan, Uma Borate, Daniel A Pollyea, Andrew M Brunner, Fernando Roncolato
American Journal of Hematology. 2023-02-01 - 11 citationsImplementation of a pharmacy-managed program for the transition of chemotherapy to the outpatient setting.Ali McBride, Christopher J Campen, James M. Camamo, Marie Maloney, Daniel O. Persky
American Journal of Health-System Pharmacy. 2018-05-01 - 1 citationsCase of relentless chronic phase of chronic myeloid leukaemia.Onyee Chan, Hao Chen, Ravitharan Krishnadasan, Faiz Anwer
BMJ Case Reports. 2016-06-22
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: